Intended for healthcare professionals

Latest dermatology news

 

Amino acid sequence could significantly reduce psoriasis symptoms

Researchers looked a naturally occurring peptide that regulates inflammation

17 Apr 2025

J&J announces positive phase 3b results for Tremfya in psoriatic arthritis

Approximately 30% of psoriasis patients are affected by psoriatic arthritis

17 Apr 2025

Organon’s Vtama cream shows sustained benefit in atopic dermatitis patients

More than 26 million people in the US are affected by the inflammatory skin disease

10 Apr 2025

Almirall hosts Skin Academy to advance skin science

The event brought together a broad range of experts and clinicians from across the world

10 Apr 2025

Novartis signs global deal for Kyorin’s chronic spontaneous urticaria candidate

KRP-M223 is being developed for CSU and other allergic and inflammatory diseases

03 Apr 2025

Amgen/Kyowa Kirin’s rocatinlimab shows promise in phase 3 atopic dermatitis trial

Up to 20% of children and 10% of adults globally are affected by the skin disease

27 Mar 2025

J&J/Protagonist share positive phase 3 results for icotrokinra in plaque psoriasis

The immune-mediated skin disease impacts over 125 million people worldwide

27 Mar 2025

EC approves Biocon’ Yesintek to treat psoriasis

The Stelara biosimilar has been authorised to treat plaque psoriasis and psoriatic arthritis

20 Mar 2025

BMS announces long-term data for Sotyktu in plaque psoriasis

At least 100 million people worldwide are affected by some form of psoriasis

20 Mar 2025

EMA committee recommends Krystal’s Vyjuvek for ultra-rare blistering disease

There is currently only one treatment authorised for dystrophic epidermolysis bullosa

19 Mar 2025
12345678910...